NovaBay Pharmaceuticals, Inc. — Form D

NovaBay Pharmaceuticals, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-28. The offering totals $226K, of which $226K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
PAUL FREIMANDirectorEMERYVILLE, CA
JULIE GARLIKOVDirectorEMERYVILLE, CA
JUSTIN HALLDirectorEMERYVILLE, CA
SWAN SITDirectorEMERYVILLE, CA
MIJIA (BOB) WUDirectorEMERYVILLE, CA
YENYOU (JEFF) ZHENGDirectorEMERYVILLE, CA
YONGXIANG (SEAN) ZHENGDirectorEMERYVILLE, CA
JUSTIN HALLExecutive OfficerEMERYVILLE, CA
TOMMY LAWExecutive OfficerEMERYVILLE, CA
Gail MaderisDirectorRedwood City, CA
Andrew JonesExecutive OfficerRiverside, MO
JEFFREY KUNINExecutive OfficerKANSAS CITY, MO
AUDREY KUNINDirectorKANSAS CITY, MO
AUDREY KUNINExecutive OfficerKANSAS CITY, MO
Mark SieczkarekDirectorEl Segundo, CA
Gail E MaderisDirectorBerkeley, CA
YENYOU (JEFF) E ZHENGDirectorEMERYVILLE, CA
PAUL E FREIMANDirectorEMERYVILLE, CA
AUDREY M KUNINExecutive OfficerKANSAS CITY, MO
SWAN E SITDirectorEMERYVILLE, CA
XINZHOU (PAUL) E LIDirectorEMERYVILLE, CA
JEFFREY M KUNINExecutive OfficerKANSAS CITY, MO
MIJIA (BOB) E WUDirectorEMERYVILLE, CA
JUSTIN M HALLDirectorEMERYVILLE, CA
JUSTIN M HALLExecutive OfficerEMERYVILLE, CA

Other filings by this issuer (18)

Showing 15 of 18 filings.

FiledFormOfferingSold
2026-01-27D$134.0M$134.0M
2024-04-05D$665K$665K
2024-01-04D$555K$555K
2023-05-18D$3.0M$3.0M
2022-09-23D$3.3M$3.3M
2022-09-23D$2.1M$2.1M
2021-11-17D$15.0M$15.0M
2020-07-31D$6.8M
2020-05-22D$1.7M$1K
2020-05-01D
2019-08-26D$4.2M$4.2M
2019-08-26D$2.7M$2.7M
2019-07-03D$2.4M$2.4M
2018-02-14D$6.0M$6.0M
2016-05-20D$11.8M$7.8M

More